Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESH: mHealth Smoking Cessation for Veterans with HIV
NCT04135937Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2019
- Primary completion
- Jul 2021
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nicotine patch, bupropion and varenicline + nicotine patch in nicotine dependence, sponsored by VA Office of Research & Development. Primary endpoint: Number of Participants Who Participate in the Post-treatment Interview at 5 weeks. Started Nov 2019; status: completed.
02
Drugs
nicotine patchbupropionvarenicline + nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04135937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04135937.